NASDAQ: SNYR) CEO Jack Ross at NASDAQ Discusses FOCUSfactor® Beverage Production, Rollout, and Expansion - Watch Now! - More Stocks Inside" src="https://www.abnewswire.com/upload/2025/10/1761758810.jpg" alt="Synergy (NASDAQ: SNYR) CEO Jack Ross at NASDAQ Discusses FOCUSfactor® Beverage Production, Rollout, and Expansion - Watch Now! - More Stocks Inside" width="225" height="225">Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, announced continued momentum for its flagship brand FOCUSfactor® following several key milestones and retail expansions across North America, UK, UAE, Turkey and Latin America.
Appearing at NASDAQ MarketSite, CEO Jack Ross discussed Synergy CHC Corp.’s accelerating rollout of FOCUSfactor® Focus + Energy ready-to-drink beverages within the rapidly expanding $100 billion-plus functional beverage market. The new line complements the brand’s clinically studied FOCUSfactor® supplements—formulated to enhance focus, memory, and cognitive clarity—while positioning the company for substantial revenue growth. Synergy CHC (NASDAQ: SNYR) currently projects approximately $40 million in revenue for 2025, marking ten consecutive profitable quarters as it scales production and retail distribution. Watch here now. Watch Entire Interview Now.
7 Active Stocks to Watch now in addition to Synergy CHC Corp. (NASDAQ: SNYR) Cambium Networks Corp (NASDAQ: CMBM), Roadzen Inc. (NASDAQ: RDZN) Ernexa Therapeutics (NASDAQ: ERNA), Genenta Science SPA (NASDAQ: GNTA) FuboTV Corp (NASDAQ: FUBO) and TOMI Environmental (NASDAQ: TOMZ) all trading actively in early trading sessions.
Synergy’s latest expansion adds distribution through Kroger Co. (NYSE: KR), Wakefern’s ShopRite Ltd. (OTC: SRHGF), and PriceSmart Inc. (NASDAQ: PSMT)—broadening availability across the U.S., Canada, and Latin America. In Canada, Fortinos, part of the Loblaw Companies (TSX: L) family, will introduce the beverages, while Pilot Flying J, a Berkshire Hathaway (NYSE: BRK.B | TSX: BRK) company, is expanding the line to 56 travel centers nationwide.
This follows FOCUSfactor’s recognition as the #1 Pharmacist-Recommended OTC Memory Supplement for 2025–2026 by Pharmacy Times and a new distribution alliance with Atlantic Importing Company to grow retail reach across Southern New England.
With distribution spanning Costco (NASDAQ: COST), Walmart (NYSE: WMT), Amazon (NASDAQ: AMZN), BJ’s (NYSE: BJ), and Walgreens (NASDAQ: WBA)—alongside new retail wins and expanding e-commerce momentum—Synergy CHC (NASDAQ: SNYR) is positioned for substantial sales growth through 2026. Analysts anticipate strong upside potential as the company captures market share in nootropics, cognitive supplements, and clean-energy beverages, sectors expected to maintain double-digit growth through the decade.
As Synergy CHC Corp. (NASDAQ: SNYR) continues to blend science, wellness, and innovation, the company stands out as a compelling story in the consumer health and functional beverage markets, appealing to both long-term investors and health-conscious consumers.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com
